These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11786882)

  • 1. Future of neuroprotective drugs in doubt.
    Birmingham K
    Nat Med; 2002 Jan; 8(1):5. PubMed ID: 11786882
    [No Abstract]   [Full Text] [Related]  

  • 2. Finding new drugs to treat stroke.
    Barinaga M
    Science; 1996 May; 272(5262):664-6. PubMed ID: 8614822
    [No Abstract]   [Full Text] [Related]  

  • 3. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.
    Muir KW
    Curr Opin Pharmacol; 2006 Feb; 6(1):53-60. PubMed ID: 16359918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenon as neuroprotectant in acute stroke?
    Altschuler EL
    Med Hypotheses; 2001 Feb; 56(2):227-8. PubMed ID: 11425293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke.
    Choi D
    Neurobiol Dis; 2000 Oct; 7(5):552-8. PubMed ID: 11042076
    [No Abstract]   [Full Text] [Related]  

  • 6. Is it time to conclude that NMDA antagonists have failed?
    Roesler R; Quevedo J; Schröder N
    Lancet Neurol; 2003 Jan; 2(1):13; discussion 13. PubMed ID: 12849294
    [No Abstract]   [Full Text] [Related]  

  • 7. [Modern aspects of investigation and clinical application of glutamatergic agents].
    Petrov VI; Onishchenko NV
    Eksp Klin Farmakol; 2002; 65(4):66-70. PubMed ID: 12449079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal ganglion cells, glaucoma and neuroprotection.
    Lipton SA
    Prog Brain Res; 2001; 131():712-8. PubMed ID: 11420983
    [No Abstract]   [Full Text] [Related]  

  • 9. An update of neuroprotectants in clinical development for acute stroke.
    Lutsep H; Clark W
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1732-6. PubMed ID: 11892936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologically activated therapeutics for neuroprotection.
    Lipton SA
    Nat Rev Neurosci; 2007 Oct; 8(10):803-8. PubMed ID: 17882256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARR 15896 AR. ARL 15896, ARL 15896AR, ARR 15896, FPL 15896, FPL 15896AR.
    Drugs R D; 1999 Jan; 1(1):14-5. PubMed ID: 10565970
    [No Abstract]   [Full Text] [Related]  

  • 13. Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition.
    Jung KH; Chu K; Lee ST; Park HK; Kim JH; Kang KM; Kim M; Lee SK; Roh JK
    Biochem Biophys Res Commun; 2009 Jan; 378(3):507-12. PubMed ID: 19056343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memantine as a neuroprotective agent in early phases of psychosis.
    Fusar-Poli P; Pellegrini F; Cortesi M
    Med Hypotheses; 2007; 68(2):459-60. PubMed ID: 17005328
    [No Abstract]   [Full Text] [Related]  

  • 15. BIII 277CL. BIII 277, BIII 281CL.
    Drugs R D; 1999 Jan; 1(1):18-9. PubMed ID: 10565972
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroprotective agents in acute ischemic stroke.
    Sareen D
    J Assoc Physicians India; 2002 Feb; 50():250-8. PubMed ID: 12038658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient safety in trials of therapy for acute ischemic stroke.
    Goldstein LB; Albers GW
    JAMA; 2002 Feb; 287(8):987. PubMed ID: 11866641
    [No Abstract]   [Full Text] [Related]  

  • 18. Lithium neuroprotection: molecular mechanisms and clinical implications.
    Rowe MK; Chuang DM
    Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.
    Lipton SA
    Nat Rev Drug Discov; 2006 Feb; 5(2):160-70. PubMed ID: 16424917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NMDA receptor antagonists: a new treatment for neuropathic pain].
    Pud D; Eisenberg E
    Harefuah; 1999 Apr; 136(7):564-7. PubMed ID: 15532603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.